1. Scrip

Novartis Unveils Zero Profit COVID-19 Drugs Portfolio

Dexamethasone On List For Low-Income Countries

 
• By Kevin Grogan

Lutz Hegemann, chief operating officer for global health at Novartis, tells Scrip the project will continue until a vaccine or curative treatments have reached the world's poorest places, not just until they are first approved in a high income country.

Coronavirus dollar bill
Novartis pledges to make no profit from COVID-19 portfolio of neds

Novartis AG has launched a first-of-its-kind portfolio of 15 generic and over-the-counter medicines, including dexamethasone, for COVID-19 symptoms to be sold at zero profit to the world's poorest countries.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip